Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis.

about

Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q36208986

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Mineralocorticoid receptor ant ...... atic review and meta-analysis.

@ast

Mineralocorticoid receptor ant ...... atic review and meta-analysis.

@en

type

Item

label

Mineralocorticoid receptor ant ...... atic review and meta-analysis.

@ast

Mineralocorticoid receptor ant ...... atic review and meta-analysis.

@en

prefLabel

Mineralocorticoid receptor ant ...... atic review and meta-analysis.

@ast

Mineralocorticoid receptor ant ...... atic review and meta-analysis.

@en

P1476

Mineralocorticoid receptor ant ...... atic review and meta-analysis.

@en

P2093

Nicolas M Berbenetz

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

Spironolactone in the treatment of congestive heart failure.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

P2888

s12872-016-0425-x

P304

246

http://www.w3.org/2001/XMLSchema#string

P31

P356

10.1186/S12872-016-0425-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marko Mrkobrada

P5008

ScienceSource

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029798865

http://www.w3.org/2001/XMLSchema#string

P698

27905877

http://www.w3.org/2001/XMLSchema#string

P921

stroke volume

heart failure

antimineralocorticoid

P932

5134129

http://www.w3.org/2001/XMLSchema#string